Advancements in Global Uterine Fibroid Embolization Devices: Revolutionizing Treatment Options

Uterine fibroid embolization (UFE) refers to a minimally invasive treatment that is widely utilized for treating fibroid tumors in the uterus. The procedure is referred as a uterine artery embolization (UAE), and is used for treating other complications such as placenta previa, arteriovenous malformations of the pelvis and placenta accrete.

Global Uterine Fibroid Embolization Devices Market was valued at USD 5.01 billion in 2021 and is expected to reach USD 7.08 billion by 2029, registering a CAGR of 4.40% during the forecast period of 2022-2029. "The minimally invasive treatment" accounts for the largest mode of treatment segment in the respective market owing to the high awareness regarding the technique among people.

Uterine Fibroid Embolization Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Prevalence of Uterine Fibroids
The rise in the prevalence of uterine fibroids among women across the acts as one of the major factors driving the growth of uterine fibroid embolization devices market.
• Preference for Minimally Invasive Surgery
The increase in the preference for minimally invasive surgery owing to the advantages, such as smaller incisions decrease post-operative pain and speedy recovery, accelerate the market growth.

Get More Info : https://www.databridgemarketresearch.com/reports/global-uterine-fibroid-embolization-devices-market

Covid-19 Impact on Uterine Fibroid Embolization Devices Market
COVID-19 had a negative impact on the uterine fibroid embolization devices market owing to the decline in elective surgeries. Hospital access was restricted to non-essential care, and O&P clinics were temporarily closed during the pandemic. The implementation of social distancing, lockdown of the population and limited access to clinics greatly affected the market. The slow-down in patient flow and referrals, and decline in trauma and workplace injuries also impacted the market growth. However, market will resume its growth in the post-pandemic due to the easing in restrictions that were imposed earlier.

Healthcare Infrastructure growth Installed base and New Technology Penetration
The uterine fibroid embolization devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for uterine fibroid embolization devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the uterine fibroid embolization devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Uterine Fibroid Embolization Devices Market Share Analysis
The uterine fibroid embolization devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to uterine fibroid embolization devices market.

Some of the major players operating in the uterine fibroid embolization devices market are
• Boston Scientific Corporation (US)
• Merit Medical Systems (US)
• BioSpace (US)
• Hologic, Inc. (US)
• Cook (UK)
• Ferring B.V. (Switzerland)
• Smith+Nephew (UK)
• CooperSurgical, Inc. (US)
• Aetna Better Health of Pennsylvania (US)
• Ethicon US, LLC (US)

More Links:
https://dbmr12232.blogspot.com/2023/07/mobile-imaging-services-market-industry_31.html

https://dbmr12232.blogspot.com/2023/07/veterinary-active-pharmaceutical_31.html

https://dbmr232343.blogspot.com/2023/08/diverticular-disease-market-industry.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.